Funds · 13F filer · Miami Beach, FL

Sabby Management, LLC

$12.0M in 16 U.S. stocks and ETFs at the end of June 30, 2026, as reported to the SEC.1

Returns–Not enough quarters yet

These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.

Top holdings

At the end of June 30, 2026. Change is in shares since the quarter before.2

StockValueShare of portfolioChange
SPYState Street Spdr S&p$4.1M34.2%+101.2%
Toyo Co LtdCUSIP G8976D107$3.5M29.1%New
Farmmi IncCUSIP G33277149$840K7.0%New
CRVOCervomed Inc$772K6.4%New
TPSTTempest Therapeutics Inc$568K4.7%+2763.4%
Paranovus Entertnmnt Tech LtCUSIP G4289N155$561K4.7%New
Bioaffinity TechnologiesCUSIP 09076W307$297K2.5%New
CREGSmart Power Corp$263K2.2%New
BCTXBriacell Therapeutics Corp$262K2.2%+9.2%
REVBRevelation Biosciences Inc$217K1.8%+111.8%
SNESSenestech Inc$211K1.8%−35.1%
BCTXLBriacell Therapeutics Corp$169K1.4%−50.0%
SIDUSidus Space Inc$122K1.0%New
INMInmed Pharmaceuticals$70K0.6%−79.6%
NUWENuwellis Inc$50K0.4%New
BCTXZBriacell Therapeutics Corp$11K0.1%−41.6%

Best picks still held

How each current holding has done since the quarter it first appeared in its filings (up to six years back).

StockHeld sinceReturn sinceNow worth
SPYState Street Spdr S&pDecember 31, 2025+9.5%$4.1M
BCTXLBriacell Therapeutics CorpMarch 31, 2026−13.6%$169K
REVBRevelation Biosciences IncMarch 31, 2026−14.2%$217K
BCTXBriacell Therapeutics CorpMarch 31, 2026−22.7%$262K
INMInmed PharmaceuticalsSeptember 30, 2025−29.2%$70K
TPSTTempest Therapeutics IncDecember 31, 2025−61.3%$568K
SNESSenestech IncSeptember 30, 2025−66.1%$211K

Sold off last quarter

  • Alphaton Capital CorpCUSIP G7185A136 was $655K
  • Big Tree Cloud Hldgs LtdCUSIP G1263B132 was $337K
  • TCToken Cat Ltd was $242K
  • Pop Culture Group Co LtdCUSIP G71700119 was $201K
  • MBRXMoleculin Biotech Inc was $172K
  • Biodexa Pharmaceuticals PLCCUSIP 59564R880 was $159K
  • RKDAArcadia Biosciences Inc was $158K
  • TRXTrx Gold Corp was $150K
  • CANFCan Fite Biofarma Ltd was $132K
  • China Sxt Pharmaceuticals IncCUSIP G2161P165 was $131K

Quarter by quarter

QuarterIts picksS&P 500
June 30, 2026+0.1%+14.8%
September 30, 2025+27.1%+7.8%
June 30, 2025+24.8%+10.5%
March 31, 2025−18.3%−4.6%
June 30, 2024−24.1%+4.0%
December 31, 2023+3.2%+11.2%
June 30, 2023−8.0%+8.3%
March 31, 2023+6.4%+7.0%
September 30, 2022−10.3%−5.3%
March 31, 2022−22.1%−4.9%
December 31, 2021−23.3%+10.7%
September 30, 2021−16.7%+0.3%

Sources

Every number on this page points here. Each one links to the public record.

  1. 1
    CIK 1535610
  2. 2
    Filed August 14, 2026 · accession 0001104659-26-096397